research centers


Search results: Found 2

Listing 1 - 2 of 2
Sort by

Article
Primary Gastric Lymphoma in North of Iraq (A Study of 34 cases in the surgical departments of Erbil and Mousl hospitals).

Author: Abdulqadir M.Zangana
Journal: Iraqi Academic Scientific Journal المجلة العراقية للاختصاصات الطبية ISSN: 16088360 Year: 2007 Volume: 6 Issue: 4 Pages: 294-302
Publisher: The Iraqi Borad for Medical Specialization المجلس العراقي للاختصاصات الطبية

Loading...
Loading...
Abstract

ABSTRACT:BACKGROUND:Primary Gastric Lymphoma is an uncommon malignancy among gastric malignancies. Histology of the Primary Gastric Lymphoma is varied and the extranodal marginal zone B-cells lymphoma is especially significant on account of its potential remission with antibiotic therapy.OBJECTIVE:To study the incidence, staging, clinical presentation, histological and management of Primary Gastric Lymphoma in the North of Iraq.PATIENTS AND METHODS:From January 1988 to February 2005, A total number of 534 patients operated as gastric tumors, 34 (4%) diagnosed as Primary Gastric Lymphoma. at the surgical departments of Erbil and Mousl teaching hospitals.RESULTS:Out of 34 Primary Gastric Lymphoma,24 cases (70.5%) were located in the distal part of the stomach the most common cell type was B-cell type non-Hodgkin's lymphoma,.Surgery was the main method of treatment and followed by chemotherapy and radiotherapy. Helicobacter pylori were isolated from all 34 Patients.All patients received antibiotics for eradication for H. Pylori infection for 4-6 weeks.Long-term remission were induced in the low-grade MALT lymphomas in 73% of cases by the successful eradication of the H. pylori infection Operative mortality rates was12 %CONCLUSION:surgical intervention was confined to stage I&II while patients with stage III surgery was indicated mostly for complications like bleeding and perforationMucosa-associated lymphoid tissue tumor (MALT) had a better prognosis because it tends to be localized with a long survival period.

Keywords

gastric lymphoma --- primary


Article
PROPOFOL - REMIFENTANIL VERSUS MIDAZOLAM - FENTANYL IN CORONARY ARTERY BYPASS GRAFT SURGERY AND INTENSIVE CARE UNIT
پروپوفول - ريميفينتانيل مقارنة ب ميدازولام - فينتانيل في عمليات زرع الشرايين التاجية والعناية المركزة

Authors: ABDULQADIR M. ZANGANA عبدالقادر زنكنة --- OTHMAN ISMAT ABDULMAJEED عثمان عصمت عبدالمجيد --- TWANA TAHER QADER توانا طاهر قادر
Journal: Duhok Medical Journal مجلة دهوك الطبية ISSN: ISSN: 20717334 (online)/ ISSN: 20717326 (Print) Year: 2017 Volume: 11 Issue: 1 Pages: 38-46
Publisher: University of Dohuk جامعة دهوك

Loading...
Loading...
Abstract

Background: In this study, we aim to identify the efficiency of propofol-remifentanil anesthesia in reducing the postoperative intensive-care unit stay in patients undergoing cardiac surgery in our center, without compromising the hemodynamic stability.Subject and Methods: Two hundred patients undergoing first time elective coronary artery bypass graft surgery were recruited in this single-centered, single-blinded, prospective and controlled study. Study patients were randomized into two treatment groups: group 1 (P-R; Propofol-Remifentanil) (n=100 patients) and group 2 (M-F; Midazolam-Fentanyl) (n=100 Patients). Clinical measurement of Mean arterial blood pressure and heart rate for each patient were recorded before (T1) and after (T2) induction of anesthesia; after sternotomy (T3) and before cardiopulmonary bypass (CPB) (T4). Time from cessation of anesthesia to tracheal extubation was also recorded (T5).Results: Comparing the hemodynamic parameters between the two groups at T1, T2, T3 and T4 set points revealed statistically significant difference (P < 0.5) in hemodynamic variables in all parameters measured apart from HR at T3. The mean recorded times from cessation of anesthesia to tracheal extubation (T5) were 99.32 minutes and 183.33 minutes in group 1 and 2, respectively. A statistically significant difference was noted between T5 in both groups (P value = 0.003).Conclusions: Our study has shown that Propofol-Remifentanil anesthesia helps to reduce the time interval between cessation of anesthesia and extubation and, by doing so, it can potentially reduce the postoperative ICU stay, without compromising hemodynamic stability

خلفية وأهداف البحث: في هذه الدراسة، هدفنا هو ايجاد فعالية دواء الپروپوفول- ريميفينتانيل لغرض تقليص وقت بقاء المريض في العناية القلبية بعد العملية لمرضى عمليات زرع الشرايين التاجية في مركزنا، دون التأثير على استقرار الفعاليات الحيوية.طرائق البحث: مائتين مريض تجرى لهم عملية زرع شرايين تاجية لاول مرة. مئة من المرضى اعطوا تخدير البروبوفول مع الريميفينتانيل ومائة مريض اعطوا تخدير الميدازولام مع الفينتانيل. المعلومات جمعت قبل اعطاء التخدير (ت١)، بعد اعطاء التخدير (ت٢)، بعد فتح عظم القص (ت٣)، قبل عمل جهاز القلب الصناعي (ت٤).(ت٥) كان الوقت بين ايقاف التخدير لحين اخراج انبوبة القصبة الهوائية. تمت المقارنة بين المجاميع للمعلومات التي جمعت.النتائج: كان هناك فرق واضح في قراءات الدورة الدموية في ت١، ت٢، ت٣ و ت٤ بين المجموعتين.الاستنتاج: بالنسبة للوقت من قطع التخدير ولغاية اخراج انبوب القصبة الهوائية كان اقصر لمجموعة البروبوفول مع الريميفينتانيل وكان وقت اخراج الانبوبة اقصر. المجموعتين من الادوية كانت امينة ومستقرة فيها فعاليات الدورة الدموية اثناء عملية زرع الشرايين التاجية.

Listing 1 - 2 of 2
Sort by
Narrow your search

Resource type

article (2)


Language

English (2)


Year
From To Submit

2017 (1)

2007 (1)